Merit E. Cudkowicz, Md
Clinical trials sponsored by Merit E. Cudkowicz, Md, explained in plain language.
-
New ALS drug trial aims to slow deadly nerve disease
Disease control CompletedThis study tested a drug called ABBV-CLS-7262 in 310 people with ALS, a progressive nerve disease that weakens muscles. The goal was to see if the drug could slow down the disease and help people live longer or maintain function. While the treatment aims to control the disease, i…
Phase: PHASE2, PHASE3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated May 26, 2026 05:34 UTC
-
New hope for ALS: DNL343 drug tested in major trial
Disease control CompletedThis study tested a drug called DNL343 in 249 people with ALS, a disease that weakens muscles over time. The goal was to see if DNL343 could slow the disease and help people live longer. The trial compared DNL343 to a placebo over 24 weeks, measuring changes in physical function …
Phase: PHASE2, PHASE3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated May 22, 2026 13:54 UTC